Diem Nguyen
CEO & DirectorDr. Diem Nguyen, Ph.D., M.B.A., is Chief Executive Officer and Director of SIGA Technologies, Inc. from January 27, 2024. Dr. Nguyen joined the SIGA Technologies, Inc. on January 27, 2024. She serves as an Independent Director of Candel Therapeutics, Inc. since July 2021. She serves as Independent Director of Verrica Pharmaceuticals Inc. since June 2020. Dr. Nguyen had been Chief Executive Officer of Xalud Therapeutics, Inc. since January 2021 until January 2024 and serves as its President and had been its Director until January 2024. Dr. Nguyen served as Executive Vice President, Biopharma, at PPD, Inc., a leading global clinical research organization providing integrated drug development, laboratory and lifecycle management services. Prior to joining PPD, she held various commercial leadership and general management roles at Pfizer, including Global President, Americas, Pfizer Essential Health and Global Sterile Injectables, where she was responsible for commercial businesses in the U.S., Latin America, Canada and Puerto Rico and led a cross-functional team with direct-line reporting for more than 5,000 commercial colleagues and manufacturing across multiple geographic sites. She also served as Pfizer’s Regional President, North America, Global Established Pharma; General Manager, Global Biosimilars; and Vice President, Established Products Strategy. Prior to Pfizer, Dr. Nguyen led corporate development, including all company-wide mergers and acquisitions and investor relations at Serologicals Corporation. Dr. Nguyen is an established leader in the pharmaceutical industry, with extensive experience spanning multiple therapeutic areas. Dr. Nguyen serves on the Boards of Directors of Verrica Pharmaceuticals Inc., Vitara Biomedical, Inc. and Children’s Hospital of Philadelphia. She received a B.A. in Chemistry with Specialization in Biochemistry from the University of Virginia, a Ph.D. in Biochemistry and Molecular Genetics from the University of Virginia and an M.B.A. in General Management from the Darden Graduate School of Business Administration at the University of Virginia.
Positions
- Company NameSIGA Technologies, Inc.Stock CodeSIGAPositionCEO & DirectorColleagues
- DJDaniel J. LuckshireExecutive VP, CFO & Secretary
- LRLawrence R. MillerGeneral Counsel & Corporate Secretary
- HVHerb VloedmanSenior VP & Chief Information Officer
- SHSuzanne HarnettSenior Vice President of Corporate Affairs & Investor Relations
- JWJoseph W. MarshallIndependent Director
- JAJaymie A. DurnanIndependent Director
- JNJulian NemirovskyIndependent Director
- HLHolly L. PhillipsIndependent Director
- Company NameVerrica Pharmaceuticals Inc.Stock CodeVRCAPositionIndependent DirectorColleagues
- JMJayson M. RiegerPresident, CEO & Director
- PBPaul B. ManningChairman of the Board
- JJJohn J. KirbyInterim Chief Financial Officer
- NLNoah L. RosenbergChief Medical Officer
- DZDavid ZawitzCOO, Chief Legal Officer & Secretary
- ESEugene ScavolaExecutive Vice President of Technical Operations
- MAMark A. PrygockiIndependent Director
- LFLawrence F. EichenfieldIndependent Director
- DNDiem NguyenIndependent Director
